Header cover image

Canadian Sustainable Track Record

Results

37

1 new

Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.

37 companies

BioSyent

Market Cap: CA$132.8m

Acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally.

RX

CA$11.65

7D

-2.1%

1Y

15.0%

Page 2 of 2